Voyageur Pharmaceuticals (CVE:VM) Trading Up 21.2% – Should You Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) traded up 21.2% during mid-day trading on Thursday . The company traded as high as C$0.21 and last traded at C$0.20. 292,294 shares changed hands during trading, a decline of 46% from the average session volume of 538,273 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Price Performance

The company has a market capitalization of C$27.89 million, a PE ratio of -20.00 and a beta of 0.32. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The firm’s 50-day moving average is C$0.10 and its 200-day moving average is C$0.07.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Recommended Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.